Diagnostic performance of multiparametric MRI in the evaluation of treatment response in glioma patients at 3T

J Liu, C Li, Y Chen, X Lv, Y Lv, J Zhou… - Journal of Magnetic …, 2020 - Wiley Online Library
… , rCBF (e), and APTw (f) maps. Multiparametric MR indices were … of a representative patient
confirmed as treatment effects. Briefly… displays hyperintense in the ADC map. Meanwhile, the …

Mapping of motor function with neuronavigated transcranial magnetic stimulation: a review on clinical application in brain tumors and methods for ensuring feasible …

N Sollmann, SM Krieg, L Säisänen, P Julkunen - Brain Sciences, 2021 - mdpi.com
… life for patients with malignant glioma as the prominent entity of intra-axial brain tumors [13,14,15,16,17,18].
To maximize the EOR while keeping surgery-related decline of function (eg, …

[HTML][HTML] Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma

EF Simonds, ED Lu, O Badillo, S Karimi… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
patients, metacluster frequencies for each primary tumor were fed into the t-stochastic neighbor
embedding (t-SNE) dimensionality reduction algorithm to produce a map of … The glioma

Value of dynamic contrast perfusion MRI to predict early response to bevacizumab in newly diagnosed glioblastoma: results from ACRIN 6686 multicenter trial

KM Schmainda, MA Prah, H Marques, E Kim… - Neuro …, 2021 - academic.oup.com
Treatment response for groups stratified by pretreatment … Of these, one-third are malignant,
of which 80% are gliomas. … across patients, NAWM was selected by one person (MAP) …

[HTML][HTML] Immune checkpoint targeted therapy in glioma: status and hopes

Y Qi, B Liu, Q Sun, X Xiong, Q Chen - Frontiers in immunology, 2020 - frontiersin.org
malignant glioma remain unknown, as the low response and persistence of treatments in
glioma … Given this, individualized treatment and real-time monitoring of treatment response are …

Anti‐tumour immune response in GL261 glioblastoma generated by Temozolomide Immune‐Enhancing Metronomic Schedule monitored with MRSI‐based …

S Wu, P Calero‐Pérez, L Villamañan… - NMR in …, 2020 - Wiley Online Library
… GL261 mouse glioma cells were obtained from the Tumour … responding to treatment, and
for calculating nosologic maps … work, we observed a transient therapy response to IMS-TMZ …

Glioblastoma: clinical presentation, diagnosis, and management

C McKinnon, M Nandhabalan, SA Murray, P Plaha - Bmj, 2021 - bmj.com
… tissue, and cortical mapping in awake patients.Tumour specimens … glioblastoma diagnosis
and monitor treatment response? … neurocognitive dysfunction in patients with diffuse glioma: a …

Decipher the glioblastoma microenvironment: the first milestone for new groundbreaking therapeutic strategies

GN Fanelli, D Grassini, V Ortenzi, F Pasqualetti… - Genes, 2021 - mdpi.com
Malignant gliomas typically contain both neoplastic cells and … ; and (iii) glioblastoma NOS,
for which full IDH evaluation … differ in prognosis and therapy response. Primary glioblastomas …

Current landscape and emerging fields of PET imaging in patients with brain tumors

JM Werner, P Lohmann, GR Fink, KJ Langen… - Molecules, 2020 - mdpi.com
… ), the assessment of treatment response to systemic treatment options such as … response
to antiangiogenic therapy with bevacizumab in patients with recurrent malignant glioma

Response to trametinib treatment in progressive pediatric low-grade glioma patients

F Selt, CM van Tilburg, B Bison, P Sievers… - Journal of Neuro …, 2020 - Springer
… dose reduction and treatment response. The severity of the AEs resulted in discontinuation
of treatment in 2/18 (11%) patients (acneiform rash in both cases). No treatment related death …